Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide - Casar-Borota, O; Heck, A; Schulz, S (J Clin Endocrinol Metab, 2013)
et al.